Free Symposium Educates on the Latest in Lung Cancer Research, Treatment
CINCINNATITo showcase advances in lung cancer research, screening and treatment, the University of Cincinnati Cancer Institutes Lung Cancer Center will host a free community event Oct. 1, aimed at educating patients on these topics and more.
According to the Centers for Disease Control and Prevention, lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the U.S., which is why education is so important, says Sandra Starnes, MD, co-director of the Lung Cancer Center, associate professor of surgery at the UC College of Medicine and UC Health thoracic surgeon.
"This community-centered symposium will help to inform patients, their families and even just interested members of the general public about the ways were working to fight this disease locally at the UC Cancer Institute, says Starnes.
"Hope! Fight! Breathe! being held from 7:30 a.m. to 1 p.m., at the Kingsgate Marriott Conference Center, 151 Goodman Drive, will update attendees on the latest in lung cancer research, screening, evaluation, treatment, survivorship and stress management. The days activities will also include a panel discussion with experts.
Presentations will center on risk factors, particularly for women, screening, ways integrative medicine can help, advances in surgical, chemotherapy and radiation, and personalized treatment for lung cancer.
"Were excited for this opportunity to raise awareness about a cancer with such devastating impact and to show that progress that is being made right here in Cincinnati, adds John Morris, MD, co-director of the Lung Cancer Center, a member of the Cincinnati Cancer Center, professor in the division of hematology oncology at the UC College of Medicine and a UC Health oncologist.
A light breakfast and boxed lunch will be provided. The event is free and open to the public, but registration is required. For more information, contact Kelly Hummel at kelly.hummel@uc.edu or 513-558-2030.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.